Evidence map›Paper›PMID 30275011›Full record

ArticleInfection and immunity2018

Polymorphisms in Receptors Involved in Opsonic and Nonopsonic Phagocytosis, and Correlation with Risk of Infection in Oncohematology Patients.

M Carmen Herrero-Sánchez, Eduardo B Angomás, Cristina de Ramón, Juan J Tellería, Luis A Corchete, Sara Alonso, M Del Carmen Ramos, María J Peñarrubia, Saioa Márquez, Nieves Fernández and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Insights into the Relationship between Pentraxin-3 and Cancer.International journal of molecular sciences · 2022
    Review
  4. Overview of Research on Germline Genetic Variation in Immune Genes and Cancer Outcomes.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  5. Article
  6. Review
  7. Review
  8. Recognition ofMicroorganisms · 2020
    Review
  9. Review
  10. Review
  11. Article
  12. Pathogens (Basel, Switzerland) · 2019
    Review
  13. Pentraxin 3 in Cardiovascular Disease.Frontiers in immunology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

M Carmen Herrero-SánchezInstituto de Biología y Genética Molecular, CSIC-Universidad de Valladolid, Valladolid, Spain.
Eduardo B AngomásServicio de Hematología, Hospital Universitario Río-Hortega, Valladolid, Spain.
Cristina de RamónServicio de Hematología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Juan J TelleríaInstituto de Biología y Genética Molecular, CSIC-Universidad de Valladolid, Valladolid, Spain.
Luis A CorcheteInstituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
Sara AlonsoInstituto de Biología y Genética Molecular, CSIC-Universidad de Valladolid, Valladolid, Spain.
M Del Carmen RamosServicio de Microbiología, Hospital Universitario Río-Hortega, Valladolid, Spain.
María J PeñarrubiaServicio de Hematología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Saioa MárquezDepartamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad de Valladolid, Valladolid, Spain.
Nieves FernándezDepartamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad de Valladolid, Valladolid, Spain.
Luis J García FradeServicio de Hematología, Hospital Universitario Río-Hortega, Valladolid, Spain.
Mariano Sánchez CrespoInstituto de Biología y Genética Molecular, CSIC-Universidad de Valladolid, Valladolid, Spain mscres@ibgm.uva.es.ORCID 0000-0002-6149-154X
Universidad de Valladolid · ESHospital Universitario Río Hortega · ESHospital Clínico Universitario de Valladolid · ESUniversidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-risk hematological malignancies are a privileged setting for infection by opportunistic microbes, with invasive mycosis being one of the most serious complications. Recently, genetic background has emerged as an unanticipated risk factor. For this reason, polymorphisms for genes encoding archetypal receptors involved in the opsonic and nonopsonic clearance of microbes, pentraxin-3 (PTX3) and Dectin-1, respectively, were studied and correlated with the risk of infection. Fungal, bacterial, and viral infections were registered for a group of 198 patients with high-risk hematological malignancies. Polymorphisms for the pentraxin-3 gene (

Indexed as

PhagocytosisAdolescentAdultAgedAged, 80 and overAntifungal AgentsAspergillosisCandidiasisChildChild, PreschoolC-Reactive ProteinDectin-1FemaleHematologic NeoplasmsHumansLectins, C-TypeAntifungal AgentsCLEC7A protein, humanC-Reactive ProteinDectin-1Lectins, C-TypePentraxinsSerum Amyloid P-ComponentDectin-1fungal infectiononcohematologyPTX3SNP

Identifiers

PMID30275011
PMCPMC6246897
OpenAlexW2901041088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.